Colleagues, I have just come across this paper that was recently published by Canadian authors in the journal JDR Clinical & Translational Research. I thought it would interest you, so I present below the publicly-available abstract along with a link to the journal, in the event that you wish to purchase the article and/or familiarize […]
It was with much pleasure that I hosted once again Dr. Mark Donaldson on CDA Oasis. Dr. Donaldson has been kind and most generous in sharing his recent publications as well as his expertise on very important pharmacological topics. Today he speaks to our audience about the liabilities dentists might incur when prescribing opioids in […]
Highlights In this short presentation, Dr. Aviv Ouanounou discusses the possible adverse effects of administering local anesthetics. Psychogenic reactions include most commonly syncope, as well as hyperventilation, nausea, and changes in heart rate and blood pressure. Allergic reactions are usually very rare and if they occur, they are usually related to the ester type of […]
Today, we bring you two interesting complex cases that were treated by Dr. Erin Watson, general dentist practicing out of Princess Margaret Cancer Center, and Dr. Irwin Golosky, Endodontist in Toronto. Both cases deal with patients who are at higher risk for medication related osteonecrosis of the jaw (MRONJ). Educational information is also presented to […]
Highlights Medication-induced salivary gland dysfunction (MISGD), xerostomia (sensation of oral dryness), and subjective sialorrhea cause significant morbidity and impair quality of life. However, no evidence-based lists of the medications that cause these disorders exist. The objective was to compile a list of medications affecting salivary gland function and inducing xerostomia or subjective sialorrhea. Data Sources […]
Dr. JoonYoung Ji returns on Oasis Discussions to speak about Fentanyl, a potent opioid that has surfaced in recent times as an abused substance responsible for many overdoses and deaths. Dr. Ji explains what Fentanyl is and why it would be found in a dental practice if ever. We hope you find the conversation valuable […]
November 13 to 19, 2017 is World Antibiotic Awareness week. I have invited Dr. Shelita Dattani, Director, Practice Development and Knowledge Translation at the Canadian Pharmacists Association, to speak to our audience about antimicrobial resistance and stewardship. The issue is at the forefront of the World Health Organization list of priorities as rising resistance becomes gradually […]
Dr. Aviv Ouanounou returns to Oasis Discussions to highlight valuable information he and his fellow authors, Dr. Goldberg and Dr. Haas, recently published related to the pharmacological management of patients suffering from temporomandibular disorders. He spke with Dr. Suham Alexander, CDA Oasis Clinical Editor. Submit a question or share your feedback with us through oasisdiscussions@cda-adc.ca […]